Vascular diseases Trials in New York, United States
Conditions / Vascular diseases / New York, United States
Vascular diseases is a medical condition with active clinical research programs worldwide.
21 total trials for this combination
Showing top 10 of 21 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT03614260 | The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension | ACTIVE_NOT_RECRUITING | NA |
| NCT05017935 | RADIANCE Continued Access Protocol | ACTIVE_NOT_RECRUITING | NA |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |
| NCT01917682 | Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions | COMPLETED | — |
| NCT01275092 | Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI) | COMPLETED | PHASE2 |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT05198674 | SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN | ACTIVE_NOT_RECRUITING | — |
| NCT02439775 | SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System | COMPLETED | NA |